BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32881660)

  • 1. Osteopontin is a Prognostic Factor in Patients with Advanced Gastric Cancer.
    Yazici O; Dogan M; Ozal G; Aktas SH; Demirkazik A; Utkan G; Senler FC; Icli F; Akbulut H
    Comb Chem High Throughput Screen; 2021; 24(8):1229-1235. PubMed ID: 32881660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated plasma osteopontin associated with gastric cancer development, invasion and survival.
    Wu CY; Wu MS; Chiang EP; Wu CC; Chen YJ; Chen CJ; Chi NH; Chen GH; Lin JT
    Gut; 2007 Jun; 56(6):782-9. PubMed ID: 17148500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin level and promoter polymorphism in patients with metastatic breast cancer.
    Elbaiomy MA; Akl T; Elhelaly R; El-Beshbishi W; El Ghonemy MS; Elzehery R
    Curr Oncol; 2020 Oct; 27(5):e444-e450. PubMed ID: 33173383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of preoperative plasma levels of osteopontin in patients with TNM stage-I of hepatocellular carcinoma.
    Sun J; Xu HM; Zhou HJ; Dong QZ; Zhao Y; Fu LY; Hei ZY; Ye QH; Ren N; Jia HL; Qin LX
    J Cancer Res Clin Oncol; 2010 Jan; 136(1):1-7. PubMed ID: 19593583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer.
    Rouanne M; Adam J; Goubar A; Robin A; Ohana C; Louvet E; Cormier J; Mercier O; Dorfmüller P; Fattal S; de Montpreville VT; Lebret T; Dartevelle P; Fadel E; Besse B; Olaussen KA; Auclair C; Soria JC
    BMC Cancer; 2016 Jul; 16():483. PubMed ID: 27422280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma.
    Zhang H; Ye QH; Ren N; Zhao L; Wang YF; Wu X; Sun HC; Wang L; Zhang BH; Liu YK; Tang ZY; Qin LX
    J Cancer Res Clin Oncol; 2006 Nov; 132(11):709-17. PubMed ID: 16786357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of osteopontin expression in cervical cancer.
    Cho H; Hong SW; Oh YJ; Kim MA; Kang ES; Lee JM; Kim SW; Kim SH; Kim JH; Kim YT; Lee K
    J Cancer Res Clin Oncol; 2008 Aug; 134(8):909-17. PubMed ID: 18210151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin is a useful predictor of bone metastasis and survival in patients with locally advanced nasopharyngeal carcinoma.
    Hou X; Wu X; Huang P; Zhan J; Zhou T; Ma Y; Qin T; Luo R; Feng Y; Xu Y; Chen L; Zhang L
    Int J Cancer; 2015 Oct; 137(7):1672-8. PubMed ID: 25824984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of osteopontin and CDX2: indications of phenotypes and prognosis in advanced gastric cancer.
    Zhang X; Tsukamoto T; Mizoshita T; Ban H; Suzuki H; Toyoda T; Tatematsu M
    Oncol Rep; 2009 Mar; 21(3):609-13. PubMed ID: 19212618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume.
    Ostheimer C; Evers C; Bache M; Reese T; Vordermark D
    Strahlenther Onkol; 2018 Jun; 194(6):539-551. PubMed ID: 29340706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinctive Prognostic Value and Cellular Functions of Osteopontin Splice Variants in Human Gastric Cancer.
    Hao C; Cui Y; Lane J; Jia S; Ji J; Jiang WG
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers.
    Cao DX; Li ZJ; Jiang XO; Lum YL; Khin E; Lee NP; Wu GH; Luk JM
    World J Gastroenterol; 2012 Aug; 18(30):3923-30. PubMed ID: 22912540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin is a prognostic circulating biomarker in patients with neuroendocrine neoplasms.
    Kidess E; Giesecke Y; Eichhorn I; Mohr R; Jann H; Fischer C; Wiedenmann B; Roderburg C; Tacke F; Sigal M
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10925-10933. PubMed ID: 37318593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of osteopontin expression in gastric cancer: a meta-analysis.
    Gu X; Gao XS; Ma M; Qin S; Qi X; Li X; Sun S; Yu H; Wang W; Zhou D
    Oncotarget; 2016 Oct; 7(43):69666-69673. PubMed ID: 27626167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of plasma osteopontin in patients with locoregionally advanced head and neck squamous cell carcinoma treated on TROG 02.02 phase III trial.
    Lim AM; Rischin D; Fisher R; Cao H; Kwok K; Truong D; McArthur GA; Young RJ; Giaccia A; Peters L; Le QT
    Clin Cancer Res; 2012 Jan; 18(1):301-7. PubMed ID: 22096023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
    Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-operative plasma osteopontin predicts distant metastasis in human colorectal cancer.
    Ng L; Wan TM; Lam CS; Chow AK; Wong SK; Man JH; Li HS; Cheng NS; Pak RC; Cheung AH; Yau TC; Lo OS; Foo DC; Poon JT; Poon RT; Pang RW; Law WL
    PLoS One; 2015; 10(5):e0126219. PubMed ID: 25961724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative changes in osteopontin and TGFβ1 plasma levels and their prognostic impact for radiotherapy in head and neck cancer.
    Polat B; Kaiser P; Wohlleben G; Gehrke T; Scherzad A; Scheich M; Malzahn U; Fischer T; Vordermark D; Flentje M
    BMC Cancer; 2017 Jan; 17(1):6. PubMed ID: 28049456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression.
    Lin CN; Wang CJ; Chao YJ; Lai MD; Shan YS
    BMC Cancer; 2015 Mar; 15():128. PubMed ID: 25872762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer.
    Blasberg JD; Pass HI; Goparaju CM; Flores RM; Lee S; Donington JS
    J Clin Oncol; 2010 Feb; 28(6):936-41. PubMed ID: 20085934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.